Tonix Pharma (TNXP) PT Raised to $27 at Raymond James
Raymond James analyst Tiago Fauth raised the price target on Tonix Pharma (NASDAQ: TNXP) to $27.00 (from $26.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
